Marizyme, Inc. (MRZM)
OTCMKTS: MRZM · Delayed Price · USD
0.0950
0.00 (0.00%)
Apr 18, 2024, 3:03 PM EDT - Market closed

Marizyme Revenue

Marizyme had revenue of $590.91K in the twelve months ending September 30, 2023, with 676.00% growth year-over-year. Revenue in the quarter ending September 30, 2023 was $181.54K with 138.82% year-over-year growth. In the year 2022, Marizyme had annual revenue of $233.49K with 11.04% growth.

Revenue (ttm)
$590.91K
Revenue Growth
+676.00%
P/S Ratio
5.69
Revenue / Employee
$45,455
Employees
13
Market Cap
3.36M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2022233.49K23.21K11.04%
Dec 31, 2021210.28K13.14K6.67%
Dec 31, 2020197.14K--
Dec 31, 20190--
Dec 31, 201820.19K-80.99K-80.05%
Dec 31, 2017101.18K-189.96K-65.25%
Dec 31, 2016291.14K-116.57K-28.59%
Dec 31, 2015407.71K--
Dec 31, 20140--
Dec 31, 20130--
Dec 31, 201225.81M-1.90M-6.86%
Mar 31, 201227.71M27.69M199,577.33%
Mar 31, 201013.88K-24.59K-63.92%
Mar 31, 200938.46K6.90K21.85%
Mar 31, 200831.57K20.39K182.56%
Mar 31, 200711.17K--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
UnitedHealth Group 371.62B
Johnson & Johnson 81.80B
Merck & Co. 60.12B
AbbVie 54.40B
Novartis AG 49.92B
AstraZeneca 47.61B
Thermo Fisher 42.49B
Abbott Laboratories 40.33B
Revenue Rankings